Editas Medicine, Inc. Quarterly Depreciation in USD from Q1 2015 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Editas Medicine, Inc. quarterly/annual Depreciation history and growth rate from Q1 2015 to Q1 2024.
  • Editas Medicine, Inc. Depreciation for the quarter ending March 31, 2024 was $1.41M, a 8.74% decline year-over-year.
  • Editas Medicine, Inc. annual Depreciation for 2023 was $6.06M, a 4.31% decline from 2022.
  • Editas Medicine, Inc. annual Depreciation for 2022 was $6.34M, a 25.4% increase from 2021.
  • Editas Medicine, Inc. annual Depreciation for 2021 was $5.05M, a 27.6% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.41M -$135K -8.74% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q1 2023 $1.54M -$14K -0.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 $1.56M +$395K +34% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q1 2021 $1.16M +$365K +45.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 $798K +$170K +27.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $628K -$123K -16.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q1 2018 $751K +$120K +19% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2017 $631K +$444K +237% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q1 2016 $187K +$104K +125% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q1 2015 $83K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.